These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3626256

  • 21. [The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].
    Sato K, Nagai H, Kurashima A, Mori M, Katayama T.
    Kekkaku; 1995 Oct; 70(10):585-9. PubMed ID: 8523851
    [Abstract] [Full Text] [Related]

  • 22. [Bacteriological evolution established in 406 tuberculosis patients treated with various combinations with or without rifampicin or INH].
    Parrot R, Augier J, Auroy C, Baron A, Boscus M, Deshais B, Gillet P, Laparre C, Marchal G, Naghavi H, Plawner S, Schoepff G.
    Rev Tuberc Pneumol (Paris); 1970 Oct; 34(5):709-13. PubMed ID: 5496793
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A, Maalej M, Zbiba M, El Gharbi T, El Mekki L, Chebbi ML, Djenayah F, Ben Salah M, El Gharbi B, Jeguirim M, Cherif M.
    Tunis Med; 1974 Oct; 52(6):305-11. PubMed ID: 4619936
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses.
    Kradolfer F, Schnell R.
    Arzneimittelforschung; 1973 Oct; 23(10):1465-6. PubMed ID: 4591315
    [No Abstract] [Full Text] [Related]

  • 27. [Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
    Oury M, Tuchais E, Viallet S, Chauvet G.
    Rev Tuberc Pneumol (Paris); 1971 Dec; 35(8):819-28. PubMed ID: 5151119
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Antitubercular therapeutic regimens routinely prescribed in Bas-Rhin and results of treatment].
    Liard R, Perdrizet S, Burghard G, Petitjean R, Rempp M, Pierau F, Chenuet J.
    Rev Mal Respir; 1986 Dec; 3(2):93-7. PubMed ID: 3726265
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Cooperative study of short-term antibacillary treatments in 14 French centers].
    Brouet G.
    Bull Int Union Tuberc; 1974 Dec; 49(1):398-410. PubMed ID: 4219734
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Resistant mycobacterium tuberculosis: report of a family in Connecticut.
    Gerstenhaber BJ.
    Conn Med; 1980 Jul; 44(7):416-8. PubMed ID: 6772373
    [No Abstract] [Full Text] [Related]

  • 40. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.